A recent NHS trial has demonstrated that precision-guided treatment informed by comprehensive molecular profiling significantly improves outcomes for children with high-risk cancers. The trial, reported in Nature Medicine by NaturePortfolio, highlights the benefits of whole genome sequencing in clinical care for children with cancer in England. This cutting-edge genetic test could replace hundreds of other tests, offering a more efficient and effective approach to treatment. The research, covered by SkyNews, supports efforts to make this test available to all children with suspected cancer to help inform individual patient care.
Why whole genome sequencing can improve child cancer treatments Read more from Sky's science and technology editor @t0mclark3 ⬇️ https://t.co/6VGG3Wk60R
A “cutting-edge” test dramatically improves the care of children with cancer and could replace hundreds of other tests, an NHS trial has found ✍️: @JanekirbyPA https://t.co/PXR4fWcy67
Whole genome sequencing has improved the care of children with cancer in England 🧬 New research supports efforts to give this test to all children with suspected #cancer to help inform individual patient care. https://t.co/nlXHSdQI3k
My copy for @PA on new study showing benefits of a genetics test for children with cancer. Thanks to @GreatOrmondSt for access https://t.co/7jUKoUGgHl
Genetic #test improves clinical care for children with #cancer in England @NatureMedicine https://t.co/2GSOgiZaVn
Data from a trial reported in @NatureMedicine show that precision-guided treatment informed by comprehensive molecular profiling significantly improves outcomes for children with high-risk cancers. https://t.co/932hOzbeDu https://t.co/YgEUrsGqyU